UNSPSC 51101663: Imidocarb
Commodity
Code facts
- Part of
-
-
51000000
-
51100000
- 51101600
-
51100000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51101663
| NIGP code |
|---|
| 26908 Anti-Infective Agents |
Definition
This classification denotes an antiprotozoal agent with the molecular formula C19H20N6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8USS3K0VDH, chemically known as 3,3-di-2-imidazolin-2-ylcarbanilide dihydrochloride but generally known as imidocarb, which bears US NIH Compound Identifier 21389. European Medicines Agency schedules Imidocarb in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08146MIG.
Read the full definition
The term IMIDOCARB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25, No. 10 1971, List 11). IMIDOCARB is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule imidocarb under HS 29332990 and SITC 51573. As of Q4 2014, IMIDOCARB remains the US FDA Preferred Term for this commodity. Imidocarb bears US NLM identifiers UMLS ID C0020928 and NCI Concept Code C83790. SMILES: O=C(NC1CC(C2=NCCN2)CCC1)NC1CC(C2=NCCN2)CCC1.
About UNSPSC 51101663
UNSPSC 51101663 Imidocarb is a Commodity code that represents pharmaceutical active pharmaceutical ingredients and finished-dose medications, though recent state and local procurement activity under this code shows limited direct alignment with imidocarb specifically. The two most recent opportunities posted under this code involve different pharmaceutical products altogether: antibiotic tablets (doxycycline hyclate and ciprofloxacin hydrochloride) and naloxone with drug deactivation systems. State and local health departments, county health authorities, and specialized health procurement consortia are the primary issuing bodies active under this code. Purchases center on pharmaceutical inventory replenishment, emergency medical countermeasures, and community health supplies acquired through competitive bidding vehicles including IFB processes and piggyback agreements with state purchasing consortia such as MMCAP Infuse.
Recent activity is concentrated in Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC (solicitation 26482DPHPREPDB53392, IFB process, response deadline September 11, 2026) for a 12-month initial term with two renewal options covering antibiotic tablets. Seminole County, Florida issued an IFB (60459723LAS, posted June 30, 2026) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, a two-year initial term plus one-year renewal option, and all-in pricing including shipping and delivery to the Seminole County Community Health Building in Sanford. Neither opportunity names explicit set-asides for disadvantaged enterprises, though the Seminole County procurement requires E-Verify compliance and may involve FEMA funding with associated federal regulatory obligations.
Quick answers
What is UNSPSC 51101663?
UNSPSC 51101663 is Imidocarb, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51101663?
UNSPSC 51101663 maps to 1 NIGP code, 26908 Anti-Infective Agents.
On GovTribe
See everything under UNSPSC 51101663
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code